SlideShare a Scribd company logo
1 of 21
Hyperthermia in Oncology
Félix Navarro Guirado
Medical Physicist
Engineer
Page 2
Content
1) What is it?
2) What for?
3) Clinical evidence?
4) How?
5) Around the world?
Hyperthermia
Page 3
Hyperthermia
1) Heat up tumors up to 41 ºC – 45 ºC (106 ºF – 113 ºF)
2) Non ablative
3) Boosting therapy for CT / RT
What is it?
What is it NOT?
Stand alone therapy
Page 4
Content
1) What is it?
2) What for?
3) Clinical evidence?
4) How?
5) Around the world?
Hyperthermia
Page 5
Hyperthermia What for?
RT/CT target: DNA DAMAGE
Int J Hypert 2012, 28(6):509-517
Who does perform DNA repair process?
How?
Hyperthermia What for?
Hyperthermia What for?
Mechanism of radiosensitization by hyperthermia as derived from studies with DNA repair defective mutant cell lines. Kampinga HH et al.,
INT. J. HYPERTHERMIA VOL. 20, NO.2(MARCH 2004), pp. 131–139
Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all.
Oei AL et al.,
Radiat Oncol. 2015 Aug 7;10:165.
Radiosensitization of heat resistant human tumour cells by 1 hour at 41.1 degrees C and its effect on DNA repair. Xu M. et al.
Int J Hyperthermia. 2002 Sep-Oct;18(5):385-403
Hyperthermia What for?
Dynamics of Cell Membrane Permeability Changes at Supraphysiological Temperatures.
J. C. Bischof,et al. Biophys J. 1995(68): 2608-2614
Membrane Effects of Ionizing Radiation and Hyperthermia.
Int J Rad Biol on Physics, Chemistry & Med. 1995 49(5):743-770
Int J Hyperthermia 2013. 29(6):528-538
Hyperthermia What for?
Hyperthermia effects:
1. DNA repair inhibition
2. Drug uptake improvement
3. Abscopal effect enhancement (HSP70Antigen collector)
4. Hypoxic volume reduction
5. Cell cycle redistribution
Page 10
Content
1) What is it?
2) What for?
3) Clinical evidence?
4) How?
5) Around the world?
Hyperthermia
Page 11
Hyperthermia
2015 Impact Factor: 3.361
8 Issues/year since 1985
Ranking: 37/125 Radiology
83/213 Oncology
Hyperthermia
Adding hyperthermia to the standard treatment has been proved to improve
respone ratio: (Level 1)
- Advanced Cervix(van der Zee 2000)
- Breast recurrency (Vernon 1996, Jones 2005)
- Soft tissue sarcoma(Issels 2008)
- H&N recurrency (Valdagni 1994)
- Advanced bladder cancer (Colombo 2003)
- Anus (Kouloulias 2005)
- Cell tumours (Wessalowski 1998)
Hyperthermia
Page 14
Content
1) What is it?
2) What for?
3) Clinical evidence?
4) How?
5) Around the world?
Hyperthermia
Hyperthermia
Hyperthermia
Page 18
Content
1) What is it?
2) What for?
3) Clinical evidence?
4) How?
5) Around the world?
Hyperthermia
Hyperthermia
Hyperthermia
Hyperthermia
Thank-you

More Related Content

What's hot

Ch 6_Energy Medicine_IN TECH
Ch 6_Energy Medicine_IN TECHCh 6_Energy Medicine_IN TECH
Ch 6_Energy Medicine_IN TECHChristina Ross
 
Chemical modifiers of radiotherapy
Chemical modifiers of radiotherapyChemical modifiers of radiotherapy
Chemical modifiers of radiotherapyDr.Saadvik Raghuram
 
electric burn disease and case profile of a patient
electric burn disease and case profile of a patient electric burn disease and case profile of a patient
electric burn disease and case profile of a patient urooj001
 
Transdermal Systemic Laser Therapy 2009
Transdermal Systemic Laser Therapy 2009Transdermal Systemic Laser Therapy 2009
Transdermal Systemic Laser Therapy 2009Dr Peter Gruenewald
 
ZMPCZM016000.11.20 TENS can reduce postoperative analgesic consumption.A meta...
ZMPCZM016000.11.20 TENS can reduce postoperative analgesic consumption.A meta...ZMPCZM016000.11.20 TENS can reduce postoperative analgesic consumption.A meta...
ZMPCZM016000.11.20 TENS can reduce postoperative analgesic consumption.A meta...painezeeman
 
Immunology in radiotherapy
Immunology in radiotherapyImmunology in radiotherapy
Immunology in radiotherapyNorman Reppingen
 

What's hot (19)

Hyperthermia in radiotherapy
Hyperthermia in radiotherapyHyperthermia in radiotherapy
Hyperthermia in radiotherapy
 
Dr jamuna's NATURAL THERAPY CENTER
Dr jamuna's NATURAL THERAPY CENTERDr jamuna's NATURAL THERAPY CENTER
Dr jamuna's NATURAL THERAPY CENTER
 
発熱と解熱剤
発熱と解熱剤発熱と解熱剤
発熱と解熱剤
 
Ch 6_Energy Medicine_IN TECH
Ch 6_Energy Medicine_IN TECHCh 6_Energy Medicine_IN TECH
Ch 6_Energy Medicine_IN TECH
 
Chemical modifiers of radiotherapy
Chemical modifiers of radiotherapyChemical modifiers of radiotherapy
Chemical modifiers of radiotherapy
 
electric burn disease and case profile of a patient
electric burn disease and case profile of a patient electric burn disease and case profile of a patient
electric burn disease and case profile of a patient
 
Allergic diseases in pregnancy
Allergic diseases in pregnancy Allergic diseases in pregnancy
Allergic diseases in pregnancy
 
Transdermal Systemic Laser Therapy 2009
Transdermal Systemic Laser Therapy 2009Transdermal Systemic Laser Therapy 2009
Transdermal Systemic Laser Therapy 2009
 
Hypersensitivity Reaction To Iodinated Contrast Media
Hypersensitivity Reaction To Iodinated Contrast MediaHypersensitivity Reaction To Iodinated Contrast Media
Hypersensitivity Reaction To Iodinated Contrast Media
 
Contrast media hypersensitivity
Contrast media hypersensitivityContrast media hypersensitivity
Contrast media hypersensitivity
 
Tobacco use and HIV
Tobacco use and HIVTobacco use and HIV
Tobacco use and HIV
 
Intralymphatic Immunotherapy
Intralymphatic ImmunotherapyIntralymphatic Immunotherapy
Intralymphatic Immunotherapy
 
ZMPCZM016000.11.20 TENS can reduce postoperative analgesic consumption.A meta...
ZMPCZM016000.11.20 TENS can reduce postoperative analgesic consumption.A meta...ZMPCZM016000.11.20 TENS can reduce postoperative analgesic consumption.A meta...
ZMPCZM016000.11.20 TENS can reduce postoperative analgesic consumption.A meta...
 
Asthma phenotypes
Asthma phenotypesAsthma phenotypes
Asthma phenotypes
 
Immunotherapy
ImmunotherapyImmunotherapy
Immunotherapy
 
Subcutaneous immunotherapy
Subcutaneous immunotherapySubcutaneous immunotherapy
Subcutaneous immunotherapy
 
Immunology in radiotherapy
Immunology in radiotherapyImmunology in radiotherapy
Immunology in radiotherapy
 
neu%2E2012%2E2782
neu%2E2012%2E2782neu%2E2012%2E2782
neu%2E2012%2E2782
 
Improving the Care of Young Patients With Atopic Dermatitis: Recognizing the ...
Improving the Care of Young Patients With Atopic Dermatitis: Recognizing the ...Improving the Care of Young Patients With Atopic Dermatitis: Recognizing the ...
Improving the Care of Young Patients With Atopic Dermatitis: Recognizing the ...
 

Viewers also liked

Cancer Hyperthermia part2
Cancer Hyperthermia part2Cancer Hyperthermia part2
Cancer Hyperthermia part2Esraa Hassanen
 
Synthesis & Heating Mechanisms of Magnetic Nanoparticles in Hyperthermia Trea...
Synthesis & Heating Mechanisms of Magnetic Nanoparticles in Hyperthermia Trea...Synthesis & Heating Mechanisms of Magnetic Nanoparticles in Hyperthermia Trea...
Synthesis & Heating Mechanisms of Magnetic Nanoparticles in Hyperthermia Trea...Nikita Gupta
 
Magnetic nanoparticles applications and bioavailability for cancer therapy
Magnetic nanoparticles applications and bioavailability for cancer therapyMagnetic nanoparticles applications and bioavailability for cancer therapy
Magnetic nanoparticles applications and bioavailability for cancer therapyPravin Chinchole
 
Magnetic fluid hyperthermia for cancer therapy
Magnetic fluid hyperthermia for cancer therapyMagnetic fluid hyperthermia for cancer therapy
Magnetic fluid hyperthermia for cancer therapyolga joy labajo
 

Viewers also liked (9)

Hyperthermia
HyperthermiaHyperthermia
Hyperthermia
 
Target Definition
Target DefinitionTarget Definition
Target Definition
 
Cancer Hyperthermia part2
Cancer Hyperthermia part2Cancer Hyperthermia part2
Cancer Hyperthermia part2
 
Synthesis & Heating Mechanisms of Magnetic Nanoparticles in Hyperthermia Trea...
Synthesis & Heating Mechanisms of Magnetic Nanoparticles in Hyperthermia Trea...Synthesis & Heating Mechanisms of Magnetic Nanoparticles in Hyperthermia Trea...
Synthesis & Heating Mechanisms of Magnetic Nanoparticles in Hyperthermia Trea...
 
What is hyperthermia? The Center for Thermal Oncology,
What is hyperthermia?            The Center for Thermal Oncology, What is hyperthermia?            The Center for Thermal Oncology,
What is hyperthermia? The Center for Thermal Oncology,
 
Hyperthermia
HyperthermiaHyperthermia
Hyperthermia
 
Magnetic nanoparticles applications and bioavailability for cancer therapy
Magnetic nanoparticles applications and bioavailability for cancer therapyMagnetic nanoparticles applications and bioavailability for cancer therapy
Magnetic nanoparticles applications and bioavailability for cancer therapy
 
Hyperthermia
HyperthermiaHyperthermia
Hyperthermia
 
Magnetic fluid hyperthermia for cancer therapy
Magnetic fluid hyperthermia for cancer therapyMagnetic fluid hyperthermia for cancer therapy
Magnetic fluid hyperthermia for cancer therapy
 

Similar to Felix Navarro - Hyperthermia

BALKAN MCO 2011 - J. Vermorken - Head and neck cancer - essential messages
BALKAN MCO 2011 - J. Vermorken - Head and neck cancer - essential messages BALKAN MCO 2011 - J. Vermorken - Head and neck cancer - essential messages
BALKAN MCO 2011 - J. Vermorken - Head and neck cancer - essential messages European School of Oncology
 
RAI resistant thyroid cancer
RAI resistant thyroid cancerRAI resistant thyroid cancer
RAI resistant thyroid cancerPLMMedical
 
MON 2011 - Slide 14 - J.B. Vermorken - Systemic therapy
MON 2011 - Slide 14 - J.B. Vermorken - Systemic therapyMON 2011 - Slide 14 - J.B. Vermorken - Systemic therapy
MON 2011 - Slide 14 - J.B. Vermorken - Systemic therapyEuropean School of Oncology
 
MCO 2011 - Slide 17 - J.B. Vermorken - Systemic therapy
MCO 2011 - Slide 17 - J.B. Vermorken - Systemic therapyMCO 2011 - Slide 17 - J.B. Vermorken - Systemic therapy
MCO 2011 - Slide 17 - J.B. Vermorken - Systemic therapyEuropean School of Oncology
 
J.B. Vermorken - Head and neck - State of the art
J.B. Vermorken - Head and neck - State of the artJ.B. Vermorken - Head and neck - State of the art
J.B. Vermorken - Head and neck - State of the artEuropean School of Oncology
 
C:\Documents And Settings\User\Desktop\Head And Neck
C:\Documents And Settings\User\Desktop\Head And NeckC:\Documents And Settings\User\Desktop\Head And Neck
C:\Documents And Settings\User\Desktop\Head And NeckGamal Abdul Hamid
 
EWMA 2014 - EP456 CHRONIC NON-HEALING WOUND MANAGEMENT WITH PLASMA TECHNOLOGY
EWMA 2014 - EP456 CHRONIC NON-HEALING WOUND MANAGEMENT WITH PLASMA TECHNOLOGYEWMA 2014 - EP456 CHRONIC NON-HEALING WOUND MANAGEMENT WITH PLASMA TECHNOLOGY
EWMA 2014 - EP456 CHRONIC NON-HEALING WOUND MANAGEMENT WITH PLASMA TECHNOLOGYEWMA
 
Perspective: Imaging for Gliomas
Perspective: Imaging for GliomasPerspective: Imaging for Gliomas
Perspective: Imaging for Gliomasasclepiuspdfs
 
Induction chemotherapy followed by concurrent ct rt versus ct-rt in advanced ...
Induction chemotherapy followed by concurrent ct rt versus ct-rt in advanced ...Induction chemotherapy followed by concurrent ct rt versus ct-rt in advanced ...
Induction chemotherapy followed by concurrent ct rt versus ct-rt in advanced ...Santam Chakraborty
 
Treatment of Non–Small-Cell Lung Cancer with Erlotinib or Gefitinib
Treatment of Non–Small-Cell Lung Cancer with Erlotinib or GefitinibTreatment of Non–Small-Cell Lung Cancer with Erlotinib or Gefitinib
Treatment of Non–Small-Cell Lung Cancer with Erlotinib or Gefitinibseayat1103
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...JohnJulie1
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...NainaAnon
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...daranisaha
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...semualkaira
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...semualkaira
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...semualkaira
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...eshaasini
 
Predict of coronary artery lesions in Kawasaki disease (川崎症-郭和昌醫師)
Predict of coronary artery lesions in Kawasaki disease (川崎症-郭和昌醫師)Predict of coronary artery lesions in Kawasaki disease (川崎症-郭和昌醫師)
Predict of coronary artery lesions in Kawasaki disease (川崎症-郭和昌醫師)Ho-Chang Kuo (郭和昌 醫師)
 

Similar to Felix Navarro - Hyperthermia (20)

BALKAN MCO 2011 - J. Vermorken - Head and neck cancer - essential messages
BALKAN MCO 2011 - J. Vermorken - Head and neck cancer - essential messages BALKAN MCO 2011 - J. Vermorken - Head and neck cancer - essential messages
BALKAN MCO 2011 - J. Vermorken - Head and neck cancer - essential messages
 
RAI resistant thyroid cancer
RAI resistant thyroid cancerRAI resistant thyroid cancer
RAI resistant thyroid cancer
 
MON 2011 - Slide 14 - J.B. Vermorken - Systemic therapy
MON 2011 - Slide 14 - J.B. Vermorken - Systemic therapyMON 2011 - Slide 14 - J.B. Vermorken - Systemic therapy
MON 2011 - Slide 14 - J.B. Vermorken - Systemic therapy
 
MCO 2011 - Slide 17 - J.B. Vermorken - Systemic therapy
MCO 2011 - Slide 17 - J.B. Vermorken - Systemic therapyMCO 2011 - Slide 17 - J.B. Vermorken - Systemic therapy
MCO 2011 - Slide 17 - J.B. Vermorken - Systemic therapy
 
J.B. Vermorken - Head and neck - State of the art
J.B. Vermorken - Head and neck - State of the artJ.B. Vermorken - Head and neck - State of the art
J.B. Vermorken - Head and neck - State of the art
 
C:\Documents And Settings\User\Desktop\Head And Neck
C:\Documents And Settings\User\Desktop\Head And NeckC:\Documents And Settings\User\Desktop\Head And Neck
C:\Documents And Settings\User\Desktop\Head And Neck
 
Homspera march2010
Homspera march2010Homspera march2010
Homspera march2010
 
EWMA 2014 - EP456 CHRONIC NON-HEALING WOUND MANAGEMENT WITH PLASMA TECHNOLOGY
EWMA 2014 - EP456 CHRONIC NON-HEALING WOUND MANAGEMENT WITH PLASMA TECHNOLOGYEWMA 2014 - EP456 CHRONIC NON-HEALING WOUND MANAGEMENT WITH PLASMA TECHNOLOGY
EWMA 2014 - EP456 CHRONIC NON-HEALING WOUND MANAGEMENT WITH PLASMA TECHNOLOGY
 
Perspective: Imaging for Gliomas
Perspective: Imaging for GliomasPerspective: Imaging for Gliomas
Perspective: Imaging for Gliomas
 
Induction chemotherapy followed by concurrent ct rt versus ct-rt in advanced ...
Induction chemotherapy followed by concurrent ct rt versus ct-rt in advanced ...Induction chemotherapy followed by concurrent ct rt versus ct-rt in advanced ...
Induction chemotherapy followed by concurrent ct rt versus ct-rt in advanced ...
 
8th hyperthermia
8th hyperthermia8th hyperthermia
8th hyperthermia
 
Treatment of Non–Small-Cell Lung Cancer with Erlotinib or Gefitinib
Treatment of Non–Small-Cell Lung Cancer with Erlotinib or GefitinibTreatment of Non–Small-Cell Lung Cancer with Erlotinib or Gefitinib
Treatment of Non–Small-Cell Lung Cancer with Erlotinib or Gefitinib
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
Predict of coronary artery lesions in Kawasaki disease (川崎症-郭和昌醫師)
Predict of coronary artery lesions in Kawasaki disease (川崎症-郭和昌醫師)Predict of coronary artery lesions in Kawasaki disease (川崎症-郭和昌醫師)
Predict of coronary artery lesions in Kawasaki disease (川崎症-郭和昌醫師)
 

More from GenesisCareUK

Dupuytrens background info
Dupuytrens background infoDupuytrens background info
Dupuytrens background infoGenesisCareUK
 
Georgina Grant - ActiFormCool
Georgina Grant - ActiFormCool Georgina Grant - ActiFormCool
Georgina Grant - ActiFormCool GenesisCareUK
 
Varian 360 Oncology and GenesisCare, Oxford
Varian 360 Oncology and GenesisCare, OxfordVarian 360 Oncology and GenesisCare, Oxford
Varian 360 Oncology and GenesisCare, OxfordGenesisCareUK
 
Lauren Knight - Managing Increasing Patient Numbers with Decreased Time Slots
Lauren Knight - Managing Increasing Patient Numbers with Decreased Time SlotsLauren Knight - Managing Increasing Patient Numbers with Decreased Time Slots
Lauren Knight - Managing Increasing Patient Numbers with Decreased Time SlotsGenesisCareUK
 
Carlos Rodrigues, GenesisCare, International.
Carlos Rodrigues, GenesisCare, International. Carlos Rodrigues, GenesisCare, International.
Carlos Rodrigues, GenesisCare, International. GenesisCareUK
 
Bernadette Lavery - Benefits of Protocol Standardisation and Evidence-Based B...
Bernadette Lavery - Benefits of Protocol Standardisation and Evidence-Based B...Bernadette Lavery - Benefits of Protocol Standardisation and Evidence-Based B...
Bernadette Lavery - Benefits of Protocol Standardisation and Evidence-Based B...GenesisCareUK
 
Jason Morton - SOP Linac Commissioning
Jason Morton - SOP Linac CommissioningJason Morton - SOP Linac Commissioning
Jason Morton - SOP Linac CommissioningGenesisCareUK
 
Professor Maria Hawkins - UK SABR Service Development Experiences
Professor Maria Hawkins - UK SABR Service Development ExperiencesProfessor Maria Hawkins - UK SABR Service Development Experiences
Professor Maria Hawkins - UK SABR Service Development ExperiencesGenesisCareUK
 
Dr Vincent Khoo, CMO, GenesisCare - MRLinac
Dr Vincent Khoo, CMO, GenesisCare - MRLinacDr Vincent Khoo, CMO, GenesisCare - MRLinac
Dr Vincent Khoo, CMO, GenesisCare - MRLinacGenesisCareUK
 
Professor Mark Glaser (Imperial College London). Proton Therapy in the UK - W...
Professor Mark Glaser (Imperial College London). Proton Therapy in the UK - W...Professor Mark Glaser (Imperial College London). Proton Therapy in the UK - W...
Professor Mark Glaser (Imperial College London). Proton Therapy in the UK - W...GenesisCareUK
 
A Collaborative Model for Continued Professional Development
A Collaborative Model for Continued Professional DevelopmentA Collaborative Model for Continued Professional Development
A Collaborative Model for Continued Professional DevelopmentGenesisCareUK
 
Adaptive Radiotherapy at GenesisCare UK
Adaptive Radiotherapy at GenesisCare UKAdaptive Radiotherapy at GenesisCare UK
Adaptive Radiotherapy at GenesisCare UKGenesisCareUK
 
Matt Hickey, Director of Clinical Strategy, - GenesisCare UK: Varian Medical ...
Matt Hickey, Director of Clinical Strategy, - GenesisCare UK: Varian Medical ...Matt Hickey, Director of Clinical Strategy, - GenesisCare UK: Varian Medical ...
Matt Hickey, Director of Clinical Strategy, - GenesisCare UK: Varian Medical ...GenesisCareUK
 
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...GenesisCareUK
 

More from GenesisCareUK (14)

Dupuytrens background info
Dupuytrens background infoDupuytrens background info
Dupuytrens background info
 
Georgina Grant - ActiFormCool
Georgina Grant - ActiFormCool Georgina Grant - ActiFormCool
Georgina Grant - ActiFormCool
 
Varian 360 Oncology and GenesisCare, Oxford
Varian 360 Oncology and GenesisCare, OxfordVarian 360 Oncology and GenesisCare, Oxford
Varian 360 Oncology and GenesisCare, Oxford
 
Lauren Knight - Managing Increasing Patient Numbers with Decreased Time Slots
Lauren Knight - Managing Increasing Patient Numbers with Decreased Time SlotsLauren Knight - Managing Increasing Patient Numbers with Decreased Time Slots
Lauren Knight - Managing Increasing Patient Numbers with Decreased Time Slots
 
Carlos Rodrigues, GenesisCare, International.
Carlos Rodrigues, GenesisCare, International. Carlos Rodrigues, GenesisCare, International.
Carlos Rodrigues, GenesisCare, International.
 
Bernadette Lavery - Benefits of Protocol Standardisation and Evidence-Based B...
Bernadette Lavery - Benefits of Protocol Standardisation and Evidence-Based B...Bernadette Lavery - Benefits of Protocol Standardisation and Evidence-Based B...
Bernadette Lavery - Benefits of Protocol Standardisation and Evidence-Based B...
 
Jason Morton - SOP Linac Commissioning
Jason Morton - SOP Linac CommissioningJason Morton - SOP Linac Commissioning
Jason Morton - SOP Linac Commissioning
 
Professor Maria Hawkins - UK SABR Service Development Experiences
Professor Maria Hawkins - UK SABR Service Development ExperiencesProfessor Maria Hawkins - UK SABR Service Development Experiences
Professor Maria Hawkins - UK SABR Service Development Experiences
 
Dr Vincent Khoo, CMO, GenesisCare - MRLinac
Dr Vincent Khoo, CMO, GenesisCare - MRLinacDr Vincent Khoo, CMO, GenesisCare - MRLinac
Dr Vincent Khoo, CMO, GenesisCare - MRLinac
 
Professor Mark Glaser (Imperial College London). Proton Therapy in the UK - W...
Professor Mark Glaser (Imperial College London). Proton Therapy in the UK - W...Professor Mark Glaser (Imperial College London). Proton Therapy in the UK - W...
Professor Mark Glaser (Imperial College London). Proton Therapy in the UK - W...
 
A Collaborative Model for Continued Professional Development
A Collaborative Model for Continued Professional DevelopmentA Collaborative Model for Continued Professional Development
A Collaborative Model for Continued Professional Development
 
Adaptive Radiotherapy at GenesisCare UK
Adaptive Radiotherapy at GenesisCare UKAdaptive Radiotherapy at GenesisCare UK
Adaptive Radiotherapy at GenesisCare UK
 
Matt Hickey, Director of Clinical Strategy, - GenesisCare UK: Varian Medical ...
Matt Hickey, Director of Clinical Strategy, - GenesisCare UK: Varian Medical ...Matt Hickey, Director of Clinical Strategy, - GenesisCare UK: Varian Medical ...
Matt Hickey, Director of Clinical Strategy, - GenesisCare UK: Varian Medical ...
 
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...
 

Recently uploaded

Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...Dr. David Greene Arizona
 
Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...mauryashreya478
 
Biology class 12 assignment neet level practise chapter wise
Biology class 12 assignment neet level practise chapter wiseBiology class 12 assignment neet level practise chapter wise
Biology class 12 assignment neet level practise chapter wiseNAGKINGRAPELLY
 
ANTIGEN- SECTION IMMUNOLOGY DEPARTMENT OF MICROBIOLOGY
ANTIGEN- SECTION IMMUNOLOGY  DEPARTMENT OF MICROBIOLOGYANTIGEN- SECTION IMMUNOLOGY  DEPARTMENT OF MICROBIOLOGY
ANTIGEN- SECTION IMMUNOLOGY DEPARTMENT OF MICROBIOLOGYDrmayuribhise
 
办理西安大略大学毕业证成绩单|购买加拿大UWO文凭证书
办理西安大略大学毕业证成绩单|购买加拿大UWO文凭证书办理西安大略大学毕业证成绩单|购买加拿大UWO文凭证书
办理西安大略大学毕业证成绩单|购买加拿大UWO文凭证书zdzoqco
 
What are weight loss medication services?
What are weight loss medication services?What are weight loss medication services?
What are weight loss medication services?Optimal Healing 4u
 
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdfExploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdfDharma Homoeopathy
 
2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology Insights2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology InsightsHealth Catalyst
 
Learn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental FogginessLearn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental Fogginessbkling
 
Text Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxText Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxProf. Satyen Bhattacharyya
 
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...The Lifesciences Magazine
 
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Oleg Kshivets
 
Critical Advancements in Healthcare Software Development | smartData Enterpri...
Critical Advancements in Healthcare Software Development | smartData Enterpri...Critical Advancements in Healthcare Software Development | smartData Enterpri...
Critical Advancements in Healthcare Software Development | smartData Enterpri...amynickle2106
 
『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书
『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书
『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书rnrncn29
 
EHR Market Growth is The Boom Over - Jasper Colin
EHR Market Growth is The Boom Over - Jasper ColinEHR Market Growth is The Boom Over - Jasper Colin
EHR Market Growth is The Boom Over - Jasper ColinJasper Colin
 
Single Assessment Framework - What We Know So Far
Single Assessment Framework - What We Know So FarSingle Assessment Framework - What We Know So Far
Single Assessment Framework - What We Know So FarCareLineLive
 
Field exchange, Issue 72 April 2024 FEX-72.pdf
Field exchange, Issue 72 April 2024 FEX-72.pdfField exchange, Issue 72 April 2024 FEX-72.pdf
Field exchange, Issue 72 April 2024 FEX-72.pdfMohamed Miyir
 

Recently uploaded (20)

Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
Innovations in Nephrology by Dr. David Greene Stem Cell Potential and Progres...
 
Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...Information about acne, detail description of their treatment by topical and ...
Information about acne, detail description of their treatment by topical and ...
 
Biology class 12 assignment neet level practise chapter wise
Biology class 12 assignment neet level practise chapter wiseBiology class 12 assignment neet level practise chapter wise
Biology class 12 assignment neet level practise chapter wise
 
ANTIGEN- SECTION IMMUNOLOGY DEPARTMENT OF MICROBIOLOGY
ANTIGEN- SECTION IMMUNOLOGY  DEPARTMENT OF MICROBIOLOGYANTIGEN- SECTION IMMUNOLOGY  DEPARTMENT OF MICROBIOLOGY
ANTIGEN- SECTION IMMUNOLOGY DEPARTMENT OF MICROBIOLOGY
 
Dr Sujit Chatterjee Hiranandani Hospital Kidney.pdf
Dr Sujit Chatterjee Hiranandani Hospital Kidney.pdfDr Sujit Chatterjee Hiranandani Hospital Kidney.pdf
Dr Sujit Chatterjee Hiranandani Hospital Kidney.pdf
 
办理西安大略大学毕业证成绩单|购买加拿大UWO文凭证书
办理西安大略大学毕业证成绩单|购买加拿大UWO文凭证书办理西安大略大学毕业证成绩单|购买加拿大UWO文凭证书
办理西安大略大学毕业证成绩单|购买加拿大UWO文凭证书
 
What are weight loss medication services?
What are weight loss medication services?What are weight loss medication services?
What are weight loss medication services?
 
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdfExploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
Exploring the Integration of Homeopathy and Allopathy in Healthcare.pdf
 
Kidney Transplant At Hiranandani Hospital
Kidney Transplant At Hiranandani HospitalKidney Transplant At Hiranandani Hospital
Kidney Transplant At Hiranandani Hospital
 
2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology Insights2024 HCAT Healthcare Technology Insights
2024 HCAT Healthcare Technology Insights
 
Learn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental FogginessLearn Tips for Managing Chemobrain or Mental Fogginess
Learn Tips for Managing Chemobrain or Mental Fogginess
 
Text Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptxText Neck Syndrome and its probable way out.pptx
Text Neck Syndrome and its probable way out.pptx
 
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
Importance of Assessing Level of Consciousness in Medical Care | The Lifescie...
 
Coping with Childhood Cancer - How Does it Hurt Today
Coping with Childhood Cancer - How Does it Hurt TodayCoping with Childhood Cancer - How Does it Hurt Today
Coping with Childhood Cancer - How Does it Hurt Today
 
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
Local Advanced Esophageal Cancer (T3-4N0-2M0): Artificial Intelligence, Syner...
 
Critical Advancements in Healthcare Software Development | smartData Enterpri...
Critical Advancements in Healthcare Software Development | smartData Enterpri...Critical Advancements in Healthcare Software Development | smartData Enterpri...
Critical Advancements in Healthcare Software Development | smartData Enterpri...
 
『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书
『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书
『澳洲文凭』买莫道克大学毕业证书成绩单办理澳洲Murdoch文凭学位证书
 
EHR Market Growth is The Boom Over - Jasper Colin
EHR Market Growth is The Boom Over - Jasper ColinEHR Market Growth is The Boom Over - Jasper Colin
EHR Market Growth is The Boom Over - Jasper Colin
 
Single Assessment Framework - What We Know So Far
Single Assessment Framework - What We Know So FarSingle Assessment Framework - What We Know So Far
Single Assessment Framework - What We Know So Far
 
Field exchange, Issue 72 April 2024 FEX-72.pdf
Field exchange, Issue 72 April 2024 FEX-72.pdfField exchange, Issue 72 April 2024 FEX-72.pdf
Field exchange, Issue 72 April 2024 FEX-72.pdf
 

Felix Navarro - Hyperthermia

  • 1. Hyperthermia in Oncology Félix Navarro Guirado Medical Physicist Engineer
  • 2. Page 2 Content 1) What is it? 2) What for? 3) Clinical evidence? 4) How? 5) Around the world? Hyperthermia
  • 3. Page 3 Hyperthermia 1) Heat up tumors up to 41 ºC – 45 ºC (106 ºF – 113 ºF) 2) Non ablative 3) Boosting therapy for CT / RT What is it? What is it NOT? Stand alone therapy
  • 4. Page 4 Content 1) What is it? 2) What for? 3) Clinical evidence? 4) How? 5) Around the world? Hyperthermia
  • 5. Page 5 Hyperthermia What for? RT/CT target: DNA DAMAGE Int J Hypert 2012, 28(6):509-517 Who does perform DNA repair process? How?
  • 7. Hyperthermia What for? Mechanism of radiosensitization by hyperthermia as derived from studies with DNA repair defective mutant cell lines. Kampinga HH et al., INT. J. HYPERTHERMIA VOL. 20, NO.2(MARCH 2004), pp. 131–139 Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all. Oei AL et al., Radiat Oncol. 2015 Aug 7;10:165. Radiosensitization of heat resistant human tumour cells by 1 hour at 41.1 degrees C and its effect on DNA repair. Xu M. et al. Int J Hyperthermia. 2002 Sep-Oct;18(5):385-403
  • 8. Hyperthermia What for? Dynamics of Cell Membrane Permeability Changes at Supraphysiological Temperatures. J. C. Bischof,et al. Biophys J. 1995(68): 2608-2614 Membrane Effects of Ionizing Radiation and Hyperthermia. Int J Rad Biol on Physics, Chemistry & Med. 1995 49(5):743-770 Int J Hyperthermia 2013. 29(6):528-538
  • 9. Hyperthermia What for? Hyperthermia effects: 1. DNA repair inhibition 2. Drug uptake improvement 3. Abscopal effect enhancement (HSP70Antigen collector) 4. Hypoxic volume reduction 5. Cell cycle redistribution
  • 10. Page 10 Content 1) What is it? 2) What for? 3) Clinical evidence? 4) How? 5) Around the world? Hyperthermia
  • 11. Page 11 Hyperthermia 2015 Impact Factor: 3.361 8 Issues/year since 1985 Ranking: 37/125 Radiology 83/213 Oncology
  • 12. Hyperthermia Adding hyperthermia to the standard treatment has been proved to improve respone ratio: (Level 1) - Advanced Cervix(van der Zee 2000) - Breast recurrency (Vernon 1996, Jones 2005) - Soft tissue sarcoma(Issels 2008) - H&N recurrency (Valdagni 1994) - Advanced bladder cancer (Colombo 2003) - Anus (Kouloulias 2005) - Cell tumours (Wessalowski 1998)
  • 14. Page 14 Content 1) What is it? 2) What for? 3) Clinical evidence? 4) How? 5) Around the world? Hyperthermia
  • 17. Page 18 Content 1) What is it? 2) What for? 3) Clinical evidence? 4) How? 5) Around the world? Hyperthermia